Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 3
2008 4
2009 3
2010 9
2011 16
2012 10
2013 8
2014 10
2015 11
2016 9
2017 8
2018 3
2019 3
2020 13
2021 10
2022 19
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL; Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group. Villemagne VL, et al. Among authors: bourgeat p. Lancet Neurol. 2013 Apr;12(4):357-67. doi: 10.1016/S1474-4422(13)70044-9. Epub 2013 Mar 8. Lancet Neurol. 2013. PMID: 23477989
Aβ-amyloid and Tau Imaging in Dementia.
Villemagne VL, Doré V, Bourgeat P, Burnham SC, Laws S, Salvado O, Masters CL, Rowe CC. Villemagne VL, et al. Among authors: bourgeat p. Semin Nucl Med. 2017 Jan;47(1):75-88. doi: 10.1053/j.semnuclmed.2016.09.006. Epub 2016 Oct 13. Semin Nucl Med. 2017. PMID: 27987560 Review.
A universal neocortical mask for Centiloid quantification.
Bourgeat P, Doré V, Rowe CC, Benzinger T, Tosun D, Goyal MS, LaMontagne P, Jin L, Weiner MW, Masters CL, Fripp J, Villemagne VL; Alzheimer's Disease Neuroimaging Initiative; OASIS3, and the AIBL research group. Bourgeat P, et al. Alzheimers Dement (Amst). 2023 Jul 21;15(3):e12457. doi: 10.1002/dad2.12457. eCollection 2023 Jul-Sep. Alzheimers Dement (Amst). 2023. PMID: 37492802 Free PMC article.
Mesial temporal tau in amyloid-β-negative cognitively normal older persons.
Krishnadas N, Doré V, Groot C, Lamb F, Bourgeat P, Burnham SC, Huang K, Goh AMY, Masters CL, Villemagne VL, Rowe CC; AIBL research group. Krishnadas N, et al. Among authors: bourgeat p. Alzheimers Res Ther. 2022 Apr 8;14(1):51. doi: 10.1186/s13195-022-00993-x. Alzheimers Res Ther. 2022. PMID: 35395950 Free PMC article.
Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease.
Krishnadas N, Huang K, Schultz SA, Doré V, Bourgeat P, Goh AMY, Lamb F, Bozinovski S, Burnham SC, Robertson JS, Laws SM, Maruff P, Masters CL, Villemagne VL, Rowe CC. Krishnadas N, et al. Among authors: bourgeat p. J Alzheimers Dis. 2022;88(4):1627-1637. doi: 10.3233/JAD-215558. J Alzheimers Dis. 2022. PMID: 35811517 Free PMC article.
Assessing Reactive Astrogliosis with 18F-SMBT-1 Across the Alzheimer Disease Spectrum.
Villemagne VL, Harada R, Doré V, Furumoto S, Mulligan R, Kudo Y, Burnham S, Krishnadas N, Bourgeat P, Xia Y, Laws S, Bozinovski S, Huang K, Ikonomovic MD, Fripp J, Yanai K, Okamura N, Rowe CC. Villemagne VL, et al. Among authors: bourgeat p. J Nucl Med. 2022 Oct;63(10):1560-1569. doi: 10.2967/jnumed.121.263255. Epub 2022 Jan 27. J Nucl Med. 2022. PMID: 35086892 Free PMC article.
Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods.
Jovalekic A, Roé-Vellvé N, Koglin N, Quintana ML, Nelson A, Diemling M, Lilja J, Gómez-González JP, Doré V, Bourgeat P, Whittington A, Gunn R, Stephens AW, Bullich S. Jovalekic A, et al. Among authors: bourgeat p. Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3276-3289. doi: 10.1007/s00259-023-06279-0. Epub 2023 Jun 10. Eur J Nucl Med Mol Imaging. 2023. PMID: 37300571 Free PMC article.
139 results